Target Name: MIR1266
NCBI ID: G100302202
Review Report on MIR1266 Target / Biomarker Content of Review Report on MIR1266 Target / Biomarker
MIR1266
Other Name(s): MicroRNA 1266 | hsa-miR-1266-3p | mir-1266 | hsa-mir-1266 | hsa-miR-1266-5p | MIRN1266 | microRNA 1266

MIR1266: A Drug Target / Disease Biomarker

MIR1266, also known as interleukin-1266, is a protein that is expressed in various tissues throughout the body. It is a key regulator of immune responses and has been implicated in a number of diseases, including cancer, autoimmune disorders, and chronic obstructive pulmonary disease (COPD). In this article, we will discuss the potential implications of MIR1266 as a drug target and biomarker.

The MIR1266 gene was identified in the genomic sequence of various organisms, including humans. It is a member of the interleukin-12 family, which includes several other proteins that play important roles in immune responses, such as MIR1262, MIR1263, and MIR1264. These proteins are involved in the regulation of cytokine signaling, immune cell function, and inflammation.

MIR1266 is a cytoplasmic protein that is expressed in a variety of tissues, including muscle, lung, liver, and pancreas. It is primarily localized to the cytoplasm of cells, but can also be found in the cell nucleus. MIR1266 is a small protein that has a calculated molecular weight of 18.1 kDa.

MIR1266 has been shown to play a key role in the regulation of immune responses. It is a negative regulator of the T-cell receptor alpha chain, which is responsible for the development and function of T cells. MIR1266 has been shown to prevent the activity of the T-cell receptor alpha chain, which is critical for the development and activation of T cells.

In addition to its role in immune regulation, MIR1266 has also been implicated in the development and progression of several diseases. For example, MIR1266 has been shown to be overexpressed in various types of cancer, including breast, lung, and colorectal cancer. It has also been linked to the development of autoimmune disorders, such as rheumatoid arthritis and lupus.

In addition to its potential clinical applications, MIR1266 has also generated a lot of interest in the research laboratory due to its unique biology and regulation. Researchers have shown that MIR1266 can be used as a potential drug target by modulating its expression or activity. For example, studies have shown that inhibiting the activity of MIR1266 can lead to the regression of cancerous tumors in animal models.

In conclusion, MIR1266 is a protein that has been shown to play a key role in immune regulation and has been implicated in the development and progression of several diseases. Its unique biology and regulation make it an attractive target for research and potential clinical applications. Further research is needed to fully understand the role of MIR1266 in disease and to develop effective therapies based on its unique properties.

Protein Name: MicroRNA 1266

The "MIR1266 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1266 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B